-
Mashup Score: 2Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics - 11 month(s) ago
Rachel Haurwitz, PhD, discusses Caribou’s clinical journey into allogeneic cell therapies, developed with proprietary genome-editing technology.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics - 11 month(s) ago
Rachel Haurwitz, PhD, discusses Caribou’s clinical journey into allogeneic cell therapies, developed with proprietary genome-editing technology.
Categories: Future of Medicine, Latest HeadlinesTweet-
Force of Nature: Caribou Biosciences Hits Clinical Runway with #CRISPR based #Cancer Therapeutics Rachel Haurwitz, PhD, discusses @CaribouBio clinical journey into allogeneic cell therapies developed with proprietary #genomeediting technology. Learn more: https://t.co/rHZDLCna9r https://t.co/PxCB73Xrpn
-
-
Mashup Score: 0Molecular Scissors Are Making the Cut … in Clinical Trials - 1 year(s) ago
Treatments based on various genome editing technologies—CRISPR, TALEN, ZFN, and meganuclease technologies—are starting to reach patients
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 8Molecular Scissors Are Making the Cut … in Clinical Trials - 1 year(s) ago
Treatments based on various genome editing technologies—CRISPR, TALEN, ZFN, and meganuclease technologies—are starting to reach patients
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 4Molecular Scissors Are Making the Cut … in Clinical Trials - 1 year(s) ago
Treatments based on various genome editing technologies—CRISPR, TALEN, ZFN, and meganuclease technologies—are starting to reach patients
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Sanofi Funds New Delivery Technology for RNA Vaccines and Therapies to the Tune of $25 Million - 1 year(s) ago
There is growing evidence that mRNA delivery systems can be adapted to enable in vivo genome editing.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 4
Study showed adding cytosine extensions to the gRNA safeguarded against Cas9 overactivity and allowed control over DNA cleavage
Categories: Future of Medicine, Latest HeadlinesTweet-
.@KyushuUniv_EN and @NagoyaUniv developed a #genomeediting method that utilizes a “safeguard single-guide RNA” to reduce the risk of mutations and possibly enable effective treatment of genetic diseases with much less risk of off-target effects. Read more: https://t.co/dbm9zidCmJ https://t.co/k1xGN0BhDa
-
-
Mashup Score: 0Prime Editing Reverses Vision Loss in Mice - 1 year(s) ago
Prime editors, transduced using an AAV system, prevent photoreceptor degeneration and reverse vision loss in mice.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Prime Editing Reverses Vision Loss in Mice - 1 year(s) ago
Prime editors, transduced using an AAV system, prevent photoreceptor degeneration and reverse vision loss in mice.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2
A recently patented genome editing tool called PASTE holds genuine promise for expanding the universe of treatable genetic diseases.
Categories: Future of Medicine, Latest HeadlinesTweet
Force of Nature: Caribou Biosciences Hits Clinical Runway with #CRISPR based #Cancer Therapeutics Rachel Haurwitz, PhD, discusses @CaribouBio clinical journey into allogeneic cell therapies developed with proprietary #genomeediting technology. Learn more: https://t.co/rHZDLCna9r https://t.co/F4K91BYWwI